Efficacy of Trovafloxacin in Treatment of Experimental Staphylococcal or Streptococcal Endocarditis
The efficacy of trovafloxacin against Staphylococcus aureus and viridans group streptococci was investigated in vitro and in an experimental model of endocarditis. The MICs at which trovafloxacin and ciprofloxacin inhibited 90% of clinical isolates of such bacteria (MIC(90)s) were (i) 0.03 and 2 mg/...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1999
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89024/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9869569/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.43.1.77 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|